Clinical Trials Logo

End Stage Renal Disease clinical trials

View clinical trials related to End Stage Renal Disease.

Filter by:

NCT ID: NCT00184652 Completed - Clinical trials for Chronic Kidney Disease

Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

Start date: April 2003
Phase: Phase 2
Study type: Interventional

This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.

NCT ID: NCT00182559 Completed - Clinical trials for End Stage Renal Disease

The Vienna Prograf and Endothelial Progenitor Cell Study

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The aim of the study is to determine if the conversion from the immunosuppressive agent cyclosporine to tacrolimus contributes to an improvement of the cardiovascular risk factors, better kidney function and immune system.

NCT ID: NCT00182156 Withdrawn - Clinical trials for Cardiovascular Diseases

Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD

Start date: October 2004
Phase:
Study type: Observational

This study is examining the effects of short daily hemodialysis on platelet function, fluid volume control, arterial stiffness and patient quality of life, as compared to conventional hemodialysis.

NCT ID: NCT00182117 Recruiting - Clinical trials for End Stage Renal Disease

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Start date: October 2003
Phase: N/A
Study type: Observational

This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

NCT ID: NCT00179218 Completed - Clinical trials for End Stage Renal Disease

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

Start date: April 2005
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

NCT ID: NCT00179205 Terminated - Clinical trials for End Stage Renal Disease

Complementary Intradialytic Nutritional Supplementation in Dialysis Patients

Start date: May 2005
Phase: Phase 2
Study type: Interventional

In this study, the investigators hypothesize that long-term administration of adequate intradialytic oral nutritional supplementation will increase visceral protein concentrations and somatic protein stores in malnourished chronic hemodialysis patients.

NCT ID: NCT00179192 Withdrawn - Clinical trials for End-Stage Renal Disease

Prevention and Treatment of Hemodialysis Vascular Access Malfunction

Start date: May 1998
Phase: Phase 2
Study type: Interventional

Vascular access is considered the Achilles heel of the dialysis patient. It constitutes the largest single cause of morbidity in the chronic hemodialysis population, accounting for over 25% of hospitalizations at an estimated cost in the US of at least one billion dollars annually. Currently, complication free survival of vascular access ranges between 30-50% a year and multiple investigative efforts in this area have been initiated and are directed at prolonging the functional life of vascular accesses. It is not well established whether intervention prior to overt malfunction or thrombosis of the vascular access could reduce these complications and thereby improve the functional longevity of the access. Moreover, once accesses at potential risk are identified, it is not well established which method of intervention, Surgery vs. Angioplasty vs. Expectant Management, is superior in terms of clinical and financial outcome. The proposed study aims to determine whether early intervention of a vascular access determined to be at risk of malfunction and thrombosis improves the long term outcome and, specifically, which means of intervention is preferred.

NCT ID: NCT00179179 Completed - Clinical trials for End Stage Renal Disease

The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis

Start date: April 2005
Phase: Phase 2
Study type: Interventional

To test the hypothesis that an exercise session combined with adequate nutritional supplementation improves skeletal muscle protein accretion during a hemodialysis session.

NCT ID: NCT00179153 Completed - Clinical trials for End Stage Renal Disease

Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee

Start date: February 2005
Phase: Phase 2
Study type: Interventional

We propose to identify malnourished chronic kidney dialysis patients through a statewide effort and subsequently treat them based on a protocol (provision of oral nutritional supplementation) over a period of six (6) months.

NCT ID: NCT00179140 Completed - Clinical trials for End Stage Renal Disease

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

Start date: November 2002
Phase: Phase 2
Study type: Interventional

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.